Progen Aav9 Elisa Kit Baculo
AAV9 Antibody |
|||
| MBS5310995-005mg | MyBiosource | 0.05mg | EUR 1455 |
×
Human IgG antibody Laboratories manufactures the progen aav9 elisa kit baculo reagents distributed by Genprice. The Progen Aav9 Elisa Kit Baculo reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Progen Inc.. Other Progen products are available in stock. Specificity: Progen Category: Aav9 Group: Elisa Kit
Rat AAV9 ELISA Kit |
||
| MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Rat AAV9 ELISA Kit |
||
| MyBiosource | 48-Strip-Wells | EUR 550 |
Rat AAV9 ELISA Kit |
||
| MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Rat AAV9 ELISA Kit |
||
| MyBiosource | 96-Strip-Wells | EUR 765 |
Mouse Anti-AAV9 antibody ELISA Kit |
||
| Creative Diagnostics | 96T | EUR 1200 |
|
Description: serum |
||
AAV9 ZsGreen |
||
| BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus Serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscles, liver, pancreas, and eye tissue. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making AAV9 a desirable candidate for therapeutic applications._x000D_These AAV9 particles constitutively express ZsGreen under a CMV promoter. ZsGreen is a human codon-optimized variant of the green fluorescent protein isolated from reef coral (Zoanthus sp). It has been engineered for higher expression in mammalian cells and is up to four times brighter than enhanced GFP (eGFP). ZsGreen expression and transduction efficiency can easily be verified and optimized by fluorescence microscopy or flow cytometry. ZsGreen has an excitation wavelength of 493 nm and an emission wavelength of 505 nm. |
||
AAV9 Luciferase |
||
| BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscle, liver, pancreas, and eye tissue. AAV8 and AAV9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making AAV9 a desirable candidate for therapeutic applications. _x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity. |
||
×
AAV9 antibody |
|||
| 10R-2483 | Fitzgerald Industries International | 5 mL | Ask for price |
AAV9 antibody |
|||
| 10R-2483S | Fitzgerald Industries International | 50 ug | Ask for price |
AAV9 Luciferase |
|||
| 78459 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscle, liver, pancreas, and eye tissue. AAV8 and AAV9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making AAV9 a desirable candidate for therapeutic applications. _x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity. |
|||
AAV9 Luciferase-eGFP |
|||
| 78468 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscle, liver, pancreas, and eye tissue. AAV8 and AAV9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making it a desirable candidate for therapeutic applications._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase and enhanced Green Fluorescent Protein (eGFP) genes connected via a T2A linker, under the control of a CMV promoter. The T2A self-cleaving peptide (derived from Thosea asigna virus 2A) leads to the efficient cleavage of the transcript and expression of luciferase and eGFP as two separate proteins. |
|||
AAV9 Luciferase-mCherry |
|||
| 78477 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscle, liver, pancreas, and eye tissue. AAV8 and AAV9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making AAV9 a desirable candidate for therapeutic applications._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase and mCherry genes connected via a T2A linker, under the control of a CMV promoter. The T2A self-cleaving peptide (derived from Thosea asigna virus 2A) leads to the efficient cleavage of the transcript and expression of luciferase and mCherry as two separate proteins. |
|||
Mouse monoclonal AAV9 antibody |
|||
| MBS5316552-005mg | MyBiosource | 0.05mg | EUR 1455 |
Mouse monoclonal AAV9 antibody |
|||
| MBS5316552-5x005mg | MyBiosource | 5x0.05mg | EUR 6385 |
saCas9 Nuclease AAV Virus (AAV9) |
|||
| K216 | ABM | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml | EUR 375 |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|||
Rat BaculoViral IAP Repeat Containing Protein 6 ELISA Kit |
|||
| MBS105825-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Rat BaculoViral IAP Repeat Containing Protein 6 ELISA Kit |
|||
| MBS105825-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Rat BaculoViral IAP Repeat Containing Protein 6 ELISA Kit |
|||
| MBS105825-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Rat BaculoViral IAP Repeat Containing Protein 6 ELISA Kit |
|||
| MBS105825-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Cat BaculoViral IAP Repeat Containing Protein 6 ELISA Kit |
|||
| MBS090403-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Fish BaculoViral IAP Repeat Containing Protein 6 ELISA Kit |
|||
| MBS107706-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Goat BaculoViral IAP Repeat Containing Protein 6 ELISA Kit |
|||
| MBS068740-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Duck BaculoViral IAP Repeat Containing Protein 6 ELISA Kit |
|||
| MBS047526-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Cavy BaculoViral IAP Repeat Containing Protein 6 ELISA Kit |
|||
| MBS052321-INQUIRE | MyBiosource | INQUIRE | Ask for price |
×
